Results 1 to 10 of about 386,960 (165)
The Pan African Medical Journal, 2018 Breast cancer is the most common type of cancer in women worldwide and the advanced stage is the first cause of cancer death in women. We report a case of a 65-year-old woman who has had nodular lesions in the right breast for 8 months, progressively ...
Nora Naqos
doaj +3 more sources
Best practices for communication of prognosis and end-of-life discussions with patients with advanced breast cancer: A report from the advanced breast cancer global alliance [PDF]
BreastPurpose: Navigating prognosis and end-of-life (EoL) communications in advanced breast cancer (ABC) is difficult for healthcare professionals, people with the disease, and their caregivers.
Lesley Fallowfield +5 more
doaj +2 more sources
Effect of race and ethnicity on advanced breast cancer risk prediction model performance [PDF]
npj Digital MedicineRace-naive prediction modeling is proposed as a method to address algorithmic bias. We evaluated model performance by removing race and ethnicity from the Breast Cancer Surveillance Consortium 6-year cumulative advanced breast cancer risk model used for ...
Karla Kerlikowske +5 more
doaj +2 more sources
Key clinical studies on changing clinical practice of advanced breast cancer in 2022 [PDF]
Zhongguo aizheng zazhi, 2023 With the improvement of comprehensive treatment of breast cancer and the continuous development of anti-tumor drugs, the survival time of breast cancer patients, especially advanced breast cancer, has been further extended. In recent years, the treatment
ZHANG Huiqiang, JIANG Zefei
doaj +3 more sources
Locally advanced breast cancer [PDF]
The Breast, 2022 Locally advanced breast cancer (LABC) is defined here as inoperable breast adenocarcinoma without distant metastases. Patients with LABC require a multidisciplinary approach. Given the risk of distant metastasis, staging exams are necessary. The incidence of LABC (stages IIIB and IIIC) has decreased in recent years.
Stefan Aebi +2 more
openaire +3 more sources
Improvement of the inactivated SARS-CoV-2 vaccine potency through formulation in alum/naloxone adjuvant; Robust T cell and anti-RBD IgG responses [PDF]
Iranian Journal of Basic Medical Sciences, 2022 Objective(s): SARS-CoV-2, emerging as a major threat to public health, has to be controlled through vaccination. Naloxone (NLX), an opioid receptor antagonist, demonstrated its adjuvant activity for microbial vaccines. In this study, inactivated SARS-CoV-
Melika Haghighi +3 more
doaj +1 more source
Journal of Materials Research and Technology, 2022 Emerging bioengineering approaches such as three-dimensional (3D) cell culture methods have opened new avenues for scaffolds combined with various therapeutic agents in bone tissue regeneration.
Esfandyar Askari +4 more
doaj +1 more source
Neglected Locally Advanced Breast Cancer: Ignorance is a Curse
Indian Journal of Medical Specialities, 2023 Breast cancer is the most common cancer worldwide. As per GLOBOCAN 2020, female breast cancer is the most commonly diagnosed cancer (11.7% of total cases).
Mayank Tripathi +3 more
doaj +1 more source
BMC Medicine, 2022 Background Triple-negative breast cancer (TNBC) is a biologically diverse disease, with characteristics such as homologous recombination deficiency (HRD), gene mutation, and immune reactions.
Takayuki Ueno +20 more
doaj +1 more source
Thymic stromal lymphopoietin-stimulated CD4+ T cells induce senescence in advanced breast cancer
Frontiers in Cell and Developmental Biology, 2022 Thymic Stromal Lymphopoietin (TSLP) plays a prominent role in inducing type 2 immune response, commonly associated with atopic diseases. TSLP-activated CD4+ T helper 2 cells block early carcinogenesis by inducing terminal differentiation in spontaneous ...
Margherita Boieri +13 more
doaj +1 more source